{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:03:37Z","timestamp":1791594217313,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1518318"],"award-info":[{"award-number":["1518318"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1805518N"],"award-info":[{"award-number":["1805518N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S23017N"],"award-info":[{"award-number":["1S23017N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C12\/16\/024"],"award-info":[{"award-number":["C12\/16\/024"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/16\/053"],"award-info":[{"award-number":["C14\/16\/053"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009550","name":"Universiteit Hasselt","doi-asserted-by":"publisher","award":["BOF17DOC11"],"award-info":[{"award-number":["BOF17DOC11"]}],"id":[{"id":"10.13039\/501100009550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01114","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T05:46:06Z","timestamp":1591681566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Live Cell Imaging Demonstrates Multiple Routes Toward a STAT1 Gain-of-Function Phenotype"],"prefix":"10.3389","volume":"11","author":[{"given":"Simone","family":"Giovannozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Gijsbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jmedgenet-2013-101570","article-title":"New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe","volume":"50","author":"Solt\u00e9sz","year":"2013","journal-title":"J Med Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3WT IPEX-like Syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.1401467","article-title":"Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody","volume":"193","author":"Yamazaki","year":"2014","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10875-014-0111-7","article-title":"Orf Infection in a patient with Stat1 gain-of-function","volume":"35","author":"Kilic","year":"2015","journal-title":"J Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","article-title":"Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation","volume":"586","author":"Kobbe","year":"2016","journal-title":"Gene."},{"key":"B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10875-016-0312-3","article-title":"Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1","volume":"36","author":"Baris","year":"2016","journal-title":"J Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/cid\/civ1220","article-title":"Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature","volume":"62","author":"Zerbe","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel STAT1 gain of function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","article-title":"Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation","volume":"38","author":"Bloomfield","year":"2018","journal-title":"J Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/odi.12881","article-title":"Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1","volume":"25","author":"Carey","year":"2019","journal-title":"Oral Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3899\/jrheum.180210","article-title":"An adult fatal case with a STAT1 gain-of-function mutation associated with multiple autoimmune diseases","volume":"46","author":"Maeshima","year":"2019","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10875-018-0554-3","article-title":"Novel STAT1 gain-of-function mutation presenting as combined immunodeficiency","volume":"38","author":"Hartono","year":"2018","journal-title":"J Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.imlet.2015.05.008","article-title":"Immunotherapy with G-CSF in patients with chronic mucocutaneous candidiasis","volume":"167","author":"van de Veerdonk","year":"2015","journal-title":"Immunol Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"M\u00f6ssner","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr Opin Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10875-013-9947-5","article-title":"A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation","volume":"33","author":"Aldave","year":"2013","journal-title":"J Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e23931","DOI":"10.4161\/jkst.23931","article-title":"Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway","volume":"2","author":"Au-Yeung","year":"2013","journal-title":"JAKSTAT."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in Immunity, immunodeficiency, and cancer","volume":"368","author":"O'Shea","year":"2013","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1073\/pnas.0501063102","article-title":"Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1073\/pnas.0802130105","article-title":"Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations","volume":"105","author":"Wenta","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1101\/gad.1485406","article-title":"Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain","volume":"20","author":"Mertens","year":"2006","journal-title":"Genes Dev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/jir.2005.25.749","article-title":"The p38 mitogen-activated protein kinase pathway in interferon signal transduction","volume":"25","author":"Katsoulidis","year":"2005","journal-title":"J Interferon Cytokine Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cellsig.2006.09.003","article-title":"STAT1 as a key modulator of cell death","volume":"19","author":"Kim","year":"2007","journal-title":"Cell Signal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1074-7613(03)00322-4","article-title":"Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-\u03b3-dependent innate immunity","volume":"19","author":"Varinou","year":"2003","journal-title":"Immunity."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1073\/pnas.0801794105","article-title":"Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain","volume":"105","author":"Sadzak","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1002\/j.1460-2075.1996.tb00946.x","article-title":"DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites","volume":"15","author":"Vinkemeier","year":"1996","journal-title":"EMBO J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.immuni.2015.04.014","article-title":"Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity","volume":"42","author":"Hirahara","year":"2015","journal-title":"Immunity."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1074\/jbc.M212972200","article-title":"A Hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response","volume":"278","author":"Kraus","year":"2003","journal-title":"J Biol Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.3390\/ijms20061445","article-title":"Differential regulation of type I and type III interferon signaling","volume":"20","author":"Stanifer","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","article-title":"Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA","volume":"93","author":"Chen","year":"1998","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.molcel.2005.02.021","article-title":"Structural bases of unphosphorylated STAT1 association and receptor binding","volume":"17","author":"Mao","year":"2005","journal-title":"Mol Cell."},{"key":"B44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2121-13-22","article-title":"Two glutamic acid residues in the DNA-binding domain are engaged in the release of STAT1 dimers from DNA","volume":"13","author":"Koch","year":"2012","journal-title":"BMC Cell Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.bpj.2018.02.035","article-title":"PAM: A framework for integrated analysis of imaging, single-molecule, and ensemble fluorescence data","volume":"114","author":"Schrimpf","year":"2018","journal-title":"Biophys J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.bpj.2016.09.012","article-title":"Arbitrary-region raster image correlation spectroscopy","volume":"111","author":"Hendrix","year":"2016","journal-title":"Biophys J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"L33","DOI":"10.1529\/biophysj.105.061788","article-title":"Fluctuation correlation spectroscopy with a laser-scanning microscope: exploiting the hidden time structure","volume":"88","author":"Digman","year":"2005","journal-title":"Biophys J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1529\/biophysj.105.079467","article-title":"Microenvironment and effect of energy depletion in the nucleus analyzed by mobility of multiple oligomeric EGFPs","volume":"91","author":"Pack","year":"2006","journal-title":"Biophys J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/153567601301800105","article-title":"A practical guide to implementing a BSL-2+ biosafety program in a research laboratory","volume":"18","author":"Duane","year":"2013","journal-title":"Appl Biosaf."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1074\/jbc.M116.753848","article-title":"Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation","volume":"292","author":"Fujiki","year":"2017","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/eji.201847955","article-title":"Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined","volume":"49","author":"Kaleviste","year":"2019","journal-title":"Eur J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3389\/fimmu.2019.01433","article-title":"STAT1 gain-of-function mutations cause high total STAT1 levels with normal dephosphorylation","volume":"10","author":"Zimmerman","year":"2019","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1101\/157271","article-title":"Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations","volume":"141","author":"Vargas-Hernandez","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molimm.2019.07.008","article-title":"Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants","volume":"114","author":"Petersen","year":"2019","journal-title":"Mol Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/gtc.12316","article-title":"Distal regulatory element of the STAT1 gene potentially mediates positive feedback control of STAT1 expression","volume":"21","author":"Yuasa","year":"2016","journal-title":"Genes Cells."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41467-020-14948-z","article-title":"Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling","volume":"11","author":"Zuo","year":"2020","journal-title":"Nat Commun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"E1855","DOI":"10.3390\/ijms18091855","article-title":"negative correlation between the diffusion coefficient and transcriptional activity of the glucocorticoid receptor","volume":"18","author":"Mikuni","year":"2017","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T05:46:08Z","timestamp":1591681568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2020.01114"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01114","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"article-number":"1114"}}